M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. I. McPhail, G. A. Sim: Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminate. In: J. Am. Chem. Soc. 88. Jahrgang, 1966, S.3888–3890, doi:10.1021/ja00968a057.
A. Lorence, C. L. Nessler: Camptothecin, over four decades of surprising findings. In: Phytochemistry. 65. Jahrgang, Nr.20, 2004, S.2735–2749, doi:10.1016/j.phytochem.2004.09.001, PMID 15474560.
Y. Yamazaki, M. Kitajima, M. Arita et al.: Biosynthesis of camptothecin. In silico and in vivo tracer study from [1-13C]glucose. In: Plant Physiol. 134. Jahrgang, Nr.1, 2004, S.161–170, doi:10.1104/pp.103.029389, PMID 14657405, PMC 316296 (freier Volltext).
D. J. Adams, M. L. Wahl, J. L. Flowers, B. Sen, M. Colvin, M. W. Dewhirst, G. Manikumar, M. C. Wani: Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient. In: Cancer Chemotherapy and Pharmacology. 57. Jahrgang, Nr.2, 2005, S.145–154, doi:10.1007/s00280-005-0008-5.
M. R. Redinbo, L. Stewart, P. Kuhn, J. J. Champoux, W. G. J. Hol: Crystal structure of human topoisomerase I in covalent and noncovalent complexes with DNA. In: Science. 279. Jahrgang, 1998, S.1504–1513, doi:10.1126/science.279.5356.1504.
R. P. Verma, C. Hansch: Camptothecins: a SAR/QSAR study. In: Chem. Rev. 109. Jahrgang, Nr.1, 2009, S.213–235, doi:10.1021/cr0780210.
A. Lorence, C. L. Nessler: Camptothecin, over four decades of surprising findings. In: Phytochemistry. 65. Jahrgang, Nr.20, 2004, S.2735–2749, doi:10.1016/j.phytochem.2004.09.001, PMID 15474560.
Y. Yamazaki, M. Kitajima, M. Arita et al.: Biosynthesis of camptothecin. In silico and in vivo tracer study from [1-13C]glucose. In: Plant Physiol. 134. Jahrgang, Nr.1, 2004, S.161–170, doi:10.1104/pp.103.029389, PMID 14657405, PMC 316296 (freier Volltext).
L. Lesueur-Ginot, D. Demarquay, R. Kiss et al.: Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. In: Cancer Res. 59. Jahrgang, Nr.12, 1999, S.2939–2943, PMID 10383158.